NanJing Pharmaceutical Co Ltd (600713) — Long-term Investment Intensity
NanJing Pharmaceutical Co Ltd (600713) has a Long-term Investment Intensity of 1.1% as of September 2019. Long-term investments of CN¥264.79 Million represent 1.1% of total assets of CN¥23.81 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See shareholders equity of NanJing Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
NanJing Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how NanJing Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 1.1%, reflecting long-term investments of CN¥264.79 Million against total assets of CN¥23.81 Billion CNY. Also explore NanJing Pharmaceutical Co Ltd assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for NanJing Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for NanJing Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NanJing Pharmaceutical Co Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 1.2% | CN¥231.68 Million | CN¥19.55 Billion | ▼ -0.1 pp |
| 2017 | 1.3% | CN¥205.91 Million | CN¥15.93 Billion | ▼ -0.4 pp |
| 2016 | 1.7% | CN¥242.94 Million | CN¥13.96 Billion | ▲ +0.5 pp |
| 2015 | 1.2% | CN¥153.63 Million | CN¥12.59 Billion | — |